Metabolically Healthy Obesity
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Obesity contributes to reduced life expectancy, impaired quality of life, and disabilities, mainly in those individuals who develop cardiovascular diseases, type 2 diabetes, osteoarthritis, and cancer. However, there is a large variation in the individual risk to developing obesity-associated comorbid diseases that cannot simply be explained by the extent of adiposity. Observations that a proportion of individuals with obesity have a significantly lower risk for cardiometabolic abnormalities led to the concept of metabolically healthy obesity (MHO). Although there is no clear definition, normal glucose and lipid metabolism parameters—in addition to the absence of hypertension—usually serve as criteria to diagnose MHO. Biological mechanisms underlying MHO lower amounts of ectopic fat (visceral and liver), and higher leg fat deposition, expandability of subcutaneous adipose tissue, preserved insulin sensitivity, and beta-cell function as well as better cardiorespiratory fitness compared to unhealthy obesity. Whereas the absence of metabolic abnormalities may reduce the risk of type 2 diabetes and cardiovascular diseases in metabolically healthy individuals compared to unhealthy individuals with obesity, it is still higher in comparison with healthy lean individuals. In addition, MHO seems to be a transient phenotype further justifying therapeutic weight loss attempts—even in this subgroup—which might not benefit from reducing body weight to the same extent as patients with unhealthy obesity. Metabolically healthy obesity represents a model to study mechanisms linking obesity to cardiometabolic complications. Metabolically healthy obesity should not be considered a safe condition, which does not require obesity treatment, but may guide decision-making for a personalized and risk-stratified obesity treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hyperplasia, referring to an increase in the number of adipocytes, is associated with an increase in subcutaneous fat volume and protective signals, and is associated with MHO (50).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
The cited source says what the claim attributes to it.
In the citing paper
“On the contrary, hypertrophic adipocytes, in which existing adipocytes enlarge, is associated with increased dysfunction and MUHO (50), which contributes to IR and subsequent T2D (52, 53).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126 · cited 7×
“8 Endocrine Reviews, June 2020, 41(3):1–16 Blüher Metabolically Healthy Obesity sex hormones may play a role in the transition from MHO to MUO.”
BackgroundInfluentialSelf-citationThe global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Cited by
Items 801–900 of 999
Mirzababaei, A., Daneshzad, E., Shiraseb, F., Pourreza, S., Setayesh, L., Clark, C. C. T., Tangestani, H., Keshavarz, S. A., & Mirzaei, K. (2021) · Research Square · doi:10.21203/rs.3.rs-304833/v1
ADIPONUTRIN LEVELS IN HYPERTENSIVE PATIENTS DEPENDING ON THE DEGREE OF OBESITY
Кравчун, П. Г., Kadykova, O. I., & Herasymchuk, U. S. (2021) · Inter Collegas · doi:10.35339/ic.8.1.10-17
“According to the World Health Organization (WHO), obesity is defined as «abnormal or excessive fat accumulation that presents a risk to health» [3, 4].”
MethodMetabolically healthy obesity: Is it really benign?
Kourris, N., & Τζιόμαλος, Κ. (2021) · Journal of Atherosclerosis Prevention and Treatment · doi:10.53590/japt.02.1019 · Cited by 1
Lamb, M. (2021) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2021-14530 · Cited by 2
Evaluation of the Pumpkin Seed Membrane as a Nutrient in the Fruit Fly Model, Fed With High Fat Diet
Güneş, E., & Bayram, Ş. (2021) · Selçuk Üniversitesi Fen Fakültesi Fen Dergisi · doi:10.35238/sufefd.957837
Yao, N., Yan, S., Li, X., Wang, L., Hu, W., Li, B., & Cui, W. (2021) · Food & Function · doi:10.1039/d1fo02621f
Şayık, D., Ahmet, A. K., ÖĞRÜNÇ, E. D., Ermiş, S. S., & Musmul, A. (2021) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.998530
Nguedjo, M. W., Ngondi, J. L., Ntentié, F. R., Azantsa, B. G. K., Javeres, M. N. L., & Oben, J. E. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4008110
Comparative safe-reduction of body weight in rats by using different doses of formalin
Ameer, S. S. A., & Abdulshahed, R. H. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.4911
Change In Metabolic Health Status Over Time And Risk Of Chronic Kidney Disease: A Prospective StudyPreprint
Cui, H., Liu, Q., Wu, Y., & Cao, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1161519/v2
Non-Alcoholic Fatty Liver Disease and Its Potential Therapeutic Strategies
Tang, Y., Yin, X., & Ma, Y. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103059 · Cited by 1
Wang, H., Fang, X., Ren, Q., Tan, X., Fan, J., & Xu, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1571956/v1
Dietary components associated with being overweight, having obesity, and cancer
Anisman, H., & Kusnecov, A. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91904-3.00018-5
Elías-López, D., Vargas‐Vázquez, A., Mehta, R., Bautista, I. C., Razo-Olvera, F. M. D., Valdés, P. A., Aguilar-Salinas, C. A., & Gómez‐Velasco, D. (2020) · Research Square · doi:10.21203/rs.3.rs-108563/v1
Prediction of changes in central hemodynamics in overweight men with further development of obesity
Nemesh, M. I., Palamarchuk, O. S., & Kentesh, O. P. (2021) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2021-42-07
Metabolic and Obesity Phenotype Trajectories in Taiwanese Medical Personnel
Chang, H.-Y., Chang, J., Chang, Y., Wu, C., & Yang, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19138184
Analysis of Metabolic Disorders and Risk Factors of Diet and Exercise Behavior in Obese Children
郭, 瑞. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1281129
Müller‐Wieland, D., & Marx, N. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-62939-0_12-1
Zaki, M. E., & Youness, E. R. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2465 · Cited by 3
Lacruz-Pleguezuelos, B., Fernández, L. P., de Molina, A. R., Pau, E. C. D. S., & Marcos-Zambrano, L. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.17.516892 · Cited by 1
Influence of fruit, meal distribution and dental health on cardio-metabolic risk
Ström, E. (2022) · Linköping University medical dissertations · doi:10.3384/9789179294489
Balarezo, E. L. E., & Tufiño, A. (2022) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v6i6.3740
Size Inclusivity in Medicine: Barriers to Healthcare Access for Patients With Obesity
Shibli-Rahhal, A. A., Ogunsakin, A. A., & Robinson, K. M. (2023) · Advances in medical education, research, and ethics (AMERE) book series · doi:10.4018/978-1-6684-5493-0.ch003
Exercise Consideration for People with Obesity Amidst Covid-19 Pandemic: a Scoping Review
Fatima, A., Rahmawati, S. E., Amatullah, D. U., & Haroen, H. (2022) · Majalah Keperawatan Unpad/Journal of Nursing Care · doi:10.24198/jnc.v5i1.36972
Cardoso, L. G. Z. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2022.tde-14022023-165009
Profile of Risk Factors for Hypertension Among Overweight Patients
Потаскалова, В. С., Селюк, М. М., Kleban, Y., & Savchuk, M. (2023) · Family medicine European practices · doi:10.30841/2786-720x.1.2023.277482
(2022) · Actual problems of modern medicine · doi:10.26565/2617-409x-2022-9
Obesity, Lipids, and Cardiovascular Disease
Bays, H. E., Alexander, L. C., & Fitch, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00016-9
Cho, S., Shin, A., Choi, J., Lee, J., & Kang, D. (2023) · Research Square · doi:10.21203/rs.3.rs-2852795/v1
Grossman, H., Cole, T. J., Shaw, C., Dissanaike, S. D., & Dhanasekara, C. S. (2023) · Burns · doi:10.1016/j.burns.2023.05.013
Cortés, P., Travers, P. M., Zeng, J. J., Ball, C. T., Lynch, S. A., & Gómez, V. (2023) · Cureus · doi:10.7759/cureus.42205 · Cited by 1
“The concept of metabolic health has started to emerge within the past few years [10,11].”
BackgroundCarbohydrate, Protein, and Fat Metabolism in Obesity
Galgani, J. E., Cortés, V., & Carrasco, F. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_21-2
Risk factors for metabolic syndrome in self‐identified and questioning sexual minority women
Choi, Y. M., Pilkerton, C. S., Xiang, J., Ashcraft, A. M., Seymour, K. A., & Szoka, N. L. (2023) · Obesity · doi:10.1002/oby.23879 · Cited by 2
Intervenção interprofissional para manejo da obesidade: estudo piloto
Gomes, G. D. A. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.108.2023.tde-23062023-112749
Editorial: Healthy adipose tissue expansion
Lee, K. Y., Emanuelli, B., & Ussar, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1287533
“However, various clinical studies have questioned the existence of a healthy obese phenotype, with most recent data suggesting that a metabolically healthy obesity is merely an intermediate state in the progression fromweight gain to the development of insulin resistance and the metabolic syndrome (Bluher, 2020).”
BackgroundCardiometabolic Function in Women
Joksimović, J., Novakovic, J. N., Jeremic, N. S., & Bradić, J. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_12 · Cited by 1
Obesity and metabolically healthy obesity: a review
Morales-Gurrola, F. G., Weyman-Vela, Y., & Simental‐Mendía, L. E. (2023) · Medicina Universitaria · doi:10.24875/rmu.23000018
Packed cell volume and its relation to obesity, gender and smoking status
Abdulqader, B. K. (2023) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2023-0047
Müller‐Wieland, D., & Marx, N. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-62932-1_12
Subtipos de obesidade e o impacto do seu conhecimento nas estratégias de tratamento
Raiter, B. T., Galhardo, A. D. A., Chen, K. T., Calazans, L. P. V., Oliveira, B. M., Almeida, V. C. L. D., Rego, M. C. D., Sanchez, R. B. D. A., Ferreira, G. H. M., & Cristovão, T. C. B. (2024) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e15837.2024
Hönemann, J., & Jordan, J. (2024) · Hypertension Research · doi:10.1038/s41440-023-01560-z
“For example, some patients with obesity do not show perturbed glucose and lipid metabolism, a phenomenon sometimes referred to as metabolic healthy obesity [3].”
BackgroundLa medicina cardiometabolica nell’obesità
(2024) · il Diabete · doi:10.30682/ildia2304d
Obesity Paradox in Cardiovascular Disease
Пиманов, С. И., Bondarenko, V. M., Владимировна, М. Е., & Бондаренко, Е. Ф. (2023) · Кардиология в Беларуси · doi:10.34883/pi.2023.15.5.008 · Cited by 1
OBESITY BECOMES A GLOBAL PROBLEM
Jurusan Ilmu Kesehatan Masyarakat, F. K. M., Lubis, F. H., Erpiani, E., Jurusan Ilmu Kesehatan Masyarakat, F. K. M., Lailan, Jurusan Ilmu Kesehatan Masyarakat, F. K. M., Ananda, A., Jurusan Ilmu Kesehatan Masyarakat, F. K. M., Ismah, Z., & Jurusan Ilmu Kesehatan Masyarakat, F. K. M. (2024) · LIFE International Journal of Health and Life-Sciences · doi:10.20319/lijhls.2022.8.156169 · Cited by 1
Blüher, M. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01150-8
Self-citationRole of surgical treatment for obesity in weight reduction and its effect on comorbidities
Pierzak, M. (2024) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/183053
Obesity: Its Status as a Disease
Hofmann, B. (2024) · Wiley eBooks · doi:10.1002/9780470015902.a0029743
Godino‐Gimeno, A. (2024) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/203148
Zeng, Z., & Xiao, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4212743/v1
Shang, W., Kong, J., Zhang, M., Zhao, L., Wang, K., & Yang, Q. (2024) · Research Square · doi:10.21203/rs.3.rs-4186551/v1
Li, G., Abudushalamu, M., & Muheremu, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4181488/v1
Erbakan, A. N., Mutlu, H. H., Uzunlulu, M., Caştur, L., Akbaş, M. M., Kaya, F. N., Erbakan, M., İşman, F. K., & Oğuz, A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050487 · Cited by 1
Adult Medicine—Western Australia
(2024) · Internal Medicine Journal · doi:10.1111/imj.4_16398
Liang, W., & Ouyang, H. (2024) · Research Square · doi:10.21203/rs.3.rs-4382905/v1
Baker, E. H., & Rutland, S. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00304-5
Chronic and Other Conditions That Increase CVD Risk
Arslanian‐Engoren, C., GARY, R. A., Irwin, C., & Zhang, W. (2024) · Springer eBooks · doi:10.1007/978-3-031-53705-9_7 · Cited by 1
Dentali, F., & Rotunno, S. (2024) · Italian Journal of Medicine · doi:10.4081/itjm.q.2024.4
Metabolisch gesunde Adipositas
Blüher, M. (2024) · Springer eBooks · doi:10.1007/978-3-662-58895-6_19
Self-citationFigueiredo, D. M., Duarte, R. P., & Cunha, C. A. D. S. (2024) · Advances in intelligent systems and computing · doi:10.1007/978-3-031-66635-3_3 · Cited by 1
Liu, Q., Si, F., Wu, Y., & Yu, J. (2024) · Obesity · doi:10.1002/oby.24122
“In practice, there exists a subset of populations with obesity who do not present with metabolic abnormalities, which is termed as metabolically healthy obesity (MHO) [10].”
Jeon, B.-J., Lee, J., Kwon, D.-H., Kim, H.-K., & Jang, G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.22.614373
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
A Novel and Comprehensive Wellness Assessment for Lifestyle‐Based Interventions
Ellison, K. M., Smith, K. A., Fernández, J. R., Plaisance, E. P., Chui, T. K., Hill, J. O., Wyatt, H. R., & Sayer, R. D. (2024) · Obesity Science & Practice · doi:10.1002/osp4.70022
Chen, X., Qiao, J., Zhu, N., Pang, J., Fei, H., Liu, Z., Cheng, F., Shi, F., & Jia, H. (2024) · Research Square · doi:10.21203/rs.3.rs-5410124/v1
Assessment, Preparation, and Medical Management
Grave, R. D., Sartirana, M., & Calugi, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-71456-6_4
Adipose Tissue Dysfunction: Clinical Implications and Complications
Dronkers, J., Lobeek, M., Meems, L. M. G., & Gorter, T. M. (2024) · Contemporary Endocrinology · doi:10.1007/978-3-031-72570-8_5
The applicability of cardiopulmonary exercise testing of young obese adults
Kelekhsaev, P. A., Varaeva, Y. R., Кislyak, O. A., & Starodubova, A. V. (2024) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov634273
Bariatric Surgery Prehabilitation
Watson, A., & Halbert, C. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-72862-4_7 · Cited by 1
Büyükyılmaz, G., & Şahan, Y. Ö. (2024) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2024.4558
Challenges and Novelties in the Treatment of Obesity in Adults. A review
Kuczapska, K., Kurowski, M., Gliwa, A., Ryglewicz, M., Fabian, D., Leszczyńska-Knaga, E., Jakubczyk, N., Rutkowska-Kawalec, W., Moczydłowski, P., & Michalczuk, K. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.77.57095
Associations between exposure to volatile organic compounds with obesity in adults
Wu, R., Jia, L., Zhu, X., Guan, G., Wang, J., Hui, R., Ma, M., Zhao, Z., Pang, H., & Zhu, L. (2025) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2024.200296 · Cited by 1
Liu, R., Zhang, Y., Hu, Z., & Deng, H. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100216
Bagheri, P., & Babaei-Sarvestani, M. H. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01555-8
“Examining MHO individuals offers a valuable opportu - nity to understand the mechanisms underlying the progression of obesity to metabolic and cardiovascular issues, as well as the development of MUO [ 16].”
Acevedo-Fernández, M., Ochoa-Précoma, R., Porchia, L. M., Posadas-Posadas, V., Torres‐Rasgado, E., González-Mejía, M. E., & López‐Bayghen, E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318413
Desai, R., Pingili, A., Mahadevan, A., Bejugam, V. R., Ahmed, H., Borra, V., Mohammed, A. S., Bondi, G., Krishnamurthy, S., Borra, N., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100167
“Therefore, it is essential to consider interventions to slow this harmful progression early, including lifestyle modifications and medical management [3].”
InfluentialThe role of adiposopathy in the development of obesity-related diseases
Kim, O. T., Дадаева, В. А., Ивановна, Л. Д., & Drapkina, O. M. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20252802196
Patel, S. A., Bull, L. N., Baradaran-Salimi, K., Shui, A. M., Siao, K., Yang, B., Maher, J. J., & Khalili, M. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70010 · Cited by 1
Loss of CTRP10 results in female obesity with preserved metabolic healthPreprint
Chen, F., Sarver, D. C., Saqib, M., Vélez, L. M., Aja, S. M., Seldin, M. M., & Wong, G. W. (2025) · eLife · doi:10.7554/elife.93373.2
Grigorian, A., Farzam, S., Moradmand, Z., Shahdadian, F., Hajhashemy, Z., Rouhani, P., & Saneei, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-92729-8
Pontali, G., Weichenberger, C. X., Rainer, J., Hantikainen, E. M., Graeve, M. D., Mattivi, F., Kob, M., Ralser, M., Pramstaller, P. P., & Domingues, F. S. (2025) · medRxiv · doi:10.1101/2025.03.10.25323679
Diet-Gut Microbiome Nexus: A New Paradigm in Food-Based Mental Disease Therapeutics
Anand, S., Kumar, P., Singh, S., Tiwari, S., Mishra, R., Uğuz, S., Saud, S., Mor, S. K., Yang, X., & McClements, D. J. (2025) · Food Reviews International · doi:10.1080/87559129.2025.2479123
“[138] The major causes of this obesity epidemic have been linked to lower levels of physical activity and higher calorie, carbohydrate, and fat consumption.”
Zheng, H., Ubeynarayana, C. U., Low, S. K. M., Moh, A. M. C., Khoo, J., Pandian, B., Soh, Y. B., Irwan, B., Wong, S. F., & Lim, S. C. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2024-099
Li, Y., Zheng, K.-Y., Liu, Z.-L., Yu, T., Zhang, W., Zhong, M., & Hu, S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i12.104952 · Cited by 1
Akbaş, N., & Uzun, A. (2025) · Journal of Medicine and Palliative Care · doi:10.47582/jompac.1640684
Sarr, O., Rajagopaul, A., Zhao, S., Wang, X., Grynspan, D., Eastabrook, G., Liang, L., Regnault, T. R. H., & de Vrijer, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.20.644371
"Obesity and metabolic abnormalities: differential associations with subclinical atherosclerosis”Preprint
González, S., Schiavone, M. A., Piñero, F., Melchiori, R. E., Brenzoni, N., García, G., Alarcon, P., Ferroni, F. E., Baratta, S., & Castellaro, C. (2025) · medRxiv · doi:10.1101/2025.03.29.25324870
Daiya, V., Archarya, S., Shukla, S., Kumar, S., Manuja, N., Jaiswal, S., Pradeep, U., Hamdulay, K., Kumar, J., & Padwal, A. (2025) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_51_24
Lyu, Y. S., & Kim, S. Y. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0306
Dong, C., Yang, C., Wan, X., & Zhou, X.-L. (2025) · Research Square · doi:10.21203/rs.3.rs-6181171/v1
Idzik, G., Kuśnierz‐Cabala, B., & Bronowicka-Adamska, P. (2025) · Zdrowie Publiczne i Zarządzanie · doi:10.4467/20842627oz.24.007.21289
Efficacy of Endoscopic Sutured Gastroplasty on Diabetes Mellitus Type 2—A Systematic Review
Beeren, F. M. M., Harker, M. J. R., van Bon, A. C., Groenen, M. J. M., & Siersema, P. D. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70057 · Cited by 1
Trends and Disparities in Clinician Diagnosis of Overweight and Obesity
Bajaj, S. S., Zhong, A., Khunte, M., & Stanford, F. C. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09633-0
Sarcospan, a candidate gene of fat distribution, may affect lipid storage in adipocytes
Dinter, K. A., Aurich, S., Müller, L., Ghosh, A., Noé, F., Wolfrum, C., Blüher, M., Hoffmann, A., Kovacs, P. L., & Keller, M. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112602
“Additionally, laboratory measurements of metabolic parameters and body composition were obtained, as detailed in earlier studies (Blüher, 2020; Kl ¨ oting et al., 2010).”
Self-citationGenetics of metabolic obesity phenotypes
Olivares-Arévalo, M., Villamil‐Ramírez, H., López-Contreras, B. E., León‐Mimila, P., Villarreal-Molina, M. T., & Canizales‐Quinteros, S. (2025) · Gaceta Médica de México · doi:10.24875/gmm.m25000970
Dobrokhotova, Y. E., Ilina, I. Y., Khlynova, S. A., Викторович, Н. Д., Павловна, Щ. С., & Дмитриевна, Ф. А. (2025) · GYNECOLOGY · doi:10.26442/20795696.2025.2.203247
Motrane, M., Farhane, H., Karchali, S., Motrane, A., Anaibar, F.-E., Abeid, S. N., Hilali, A., & Harich, N. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3187
HOOK1 Gene Expression and DNA Methylation in Obesity and Related Cardiometabolic Traits
Svensson, S. I. A., Saeed, S., Hoffmann, A., Ghosh, A., Wolfrum, C., Dahl, M. B., Çayır, A., Rønningen, T., Bai, B., Mala, T., et al. (2025) · Obesity Facts · doi:10.1159/000547603
Self-citationPython cardiomyocytes store lipids to buffer against hyperlipidemia
Tan, Y., Peter, A. K., Ozeroff, C. D., & Leinwand, L. A. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15402 · Cited by 1
“30 Despite the lackofbodymassindexstandardstodefineobesityinpythons,ourdata suggest the frequently fed Burmese python could represent a model of metabolically healthy obesity with a high capacity to buffer against chroniclipidoverload.”
Metadata
- Authors
- Blüher, M.
- Affiliations
- Helmholtz Munich (DE)
- Corresponding author
- Blüher, Matthias
- ORCID
- Blüher, Matthias
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2020-03-04
- Volume
- 41
- Issue
- 3
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7098708
- OpenAlex
- W3009496837
- Cited by
- 1,090
- References
- 123
- Citations by year
- 2026: 197 · 2025: 222 · 2024: 213 · 2023: 162 · 2022: 155 · 2021: 105 · 2020: 35
- FWCI
- 86.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (209933838)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- metabolically healthy obesity, obesity, cardiometabolic risk, type 2 diabetes, cardiovascular disease, insulin sensitivity, beta-cell function, ectopic fat, visceral fat, liver fat, leg fat, cardiorespiratory fitness, weight loss, obesity treatment, risk stratification
- MeSH terms
- Obesity, Metabolically Benign, Cardiometabolic Risk Factors, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.